Barely Significant
← all excerpts

Montelukast Use Decreases Cardiovascular Events in Asthmatics.

Front Pharmacol · 2020 · PMC7838535 · PMID 33519477

Europe PMCDOI
1
hedged sentence
0.0065
closest p · 0.1× alpha
0.0065
boldest claim

The sentences

highly significantp = 0.0065actually significant
This analysis showed a highly significant ( p = 0.0065) prevention of CV events (HR = 0.222) in the cohort exposed to montelukast.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.